Skip to main content

Livelsberger Financial Advisory

Location
Ashland, OH
Portfolio Value
Micro $2,441,954
Diversification
Highly concentrated
Filing Date
Global Rank
#7,873 / 7,986 ▼ 87 · as of Sep 2025
Top Industry
Drug Manufacturers - General 43.4%
3Y Alpha vs SPY
-4.7%
Period ended 9 months ago
Filed Oct 14, 2025 · 9mo
8 quarters · since Dec 2023

Clone Performance

Feb 2024–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+38.3%
SPY
+54.1%
Annualised alpha
-5.3%
Max drawdown
−17.8%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

5 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025
Top Position
43.4%
+26.1 pts
Top 5
100.0%
+56.7 pts
Top 10
100.0%
+41.8 pts
HHI
2,746
Dec 2023 → Sep 2025 · range 587 – 3,228
Highly concentrated+2,159

Portfolio Trend

8 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2025
Sector % Portfolio Value
Healthcare 61.4% $1,498,838
Technology 28.3% $690,653
Industrials 10.3% $252,463

Last Quarter's Activity

Export CSV
Sep 30, 2025 vs Jun 30, 2025

Added To

Positions the filer increased
4 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
No qualifying positions this quarter.

New Positions

Positions the filer opened this quarter
No qualifying positions this quarter.

Sold Out

Positions the filer fully exited
25 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
5 positions · $2,441,954 total · as of Sep 30, 2025
Ticker Company Shares Value (USD) % of Portfolio History